Apical hypertrophic cardiomyopathy

Yamaguchi syndrome

  • Nathalia Buitrago Gomez Universidad Libre (Cali, Colombia)
  • Alvaro Herrera-Escandón Universidad del Valle (Cali, Colombia)
  • Alberto Negrete-Salcedo Universidad del Valle (Cali, Colombia)
  • Carmen Quiñones-Calvache Clínica Imbanaco (Cali, Colombia)

Abstract

Introduction: apical hypertrophic cardiomyopathy (HCM) accounts for 15% of patients with HCM in Japan. However, in our country it is a rare diagnosis. In this entity, the apex is almost exclusively affected, most commonly in the left ventricle. It is diagnosed by finding apical thickening greater than 15 mm or a ratio of left ventricular apical to basal wall thickness ?1.3-1.5. It is treated symptomatically with beta blockers and automatic defibrillator implantation for primary prevention of sudden death.

Case presentation: a 59-year-old patient in whom apical HCM, or Yamaguchi syndrome, was found incidentally.

Conclusion: apical HCM is a rare entity, in many cases asymptomatic. Its prompt diagnosis allows early treatment and prevents cardiovascular outcomes, including fatal ones.

Metrics

Metrics Loading ...

Author Biographies

Alvaro Herrera-Escandón, Universidad del Valle (Cali, Colombia)

Internista, Cardiólogo. Profesor Asistente Departamento de Medicina Interna, Universidad del Valle

Alberto Negrete-Salcedo, Universidad del Valle (Cali, Colombia)

Internista, Cardiólogo. Profesor Asistente Departamento de Medicina Interna, Universidad del Valle, DIME Clínica Neurocardiovascular. Cardiólogo Electrofisiólogo Clínica Imbanaco

Carmen Quiñones-Calvache, Clínica Imbanaco (Cali, Colombia)

Médica General Clínica Imbanaco. Cali (Colombia)

Published
2021-04-06
How to Cite
Buitrago Gomez, N., Herrera-Escandón, A., Negrete-Salcedo, A., & Quiñones-Calvache, C. (2021). Apical hypertrophic cardiomyopathy: Yamaguchi syndrome. Acta Médica Colombiana, 46(4). https://doi.org/10.36104/amc.2021.2082